A hematopoietic stem cell transplant and a clinic's "stem cell injection" share a name, but they are different treatments with different cells, purposes and evidence. A transplant is an established medical procedure for blood cancers such as leukemia and lymphoma and for some blood disorders. A clinic injection usually means infusing cultured mesenchymal stem cells, which are then promoted for conditions such as joint pain, chronic illness or aging, where the evidence is much weaker.
This article explains the two, where they differ, and why the difference matters if you are considering treatment in Japan.
What a hematopoietic stem cell transplant does
Leukemia is a cancer of the blood-forming system, in which abnormal white blood cells multiply without maturing and crowd out normal blood production. Treating it often requires high-dose chemotherapy or radiotherapy, which also damages a patient's own blood-forming cells.
A hematopoietic stem cell transplant replaces those cells. Healthy blood-forming stem cells are given to the patient, and they settle in the bone marrow and rebuild red cells, white cells and platelets. The procedure is run by hematology specialists, and whether a patient is suitable depends on the disease, its stage, and the patient's general health.
Transplants come in two main types:
- Autologous transplant, in which the patient's own stem cells are collected and returned after treatment.
- Allogeneic transplant, in which stem cells come from a matched donor. A major complication of allogeneic transplant is graft-versus-host disease, in which the donor's immune cells attack the patient's tissues.
A transplant is a serious procedure with serious risks, including infection, bleeding, organ damage and graft-versus-host disease. That is why the decision is made by a transplant team after a full assessment of the disease and the patient, and why it is not comparable to an outpatient injection.
Where the cells come from
Blood-forming stem cells are obtained from three main sources: bone marrow, peripheral blood, and umbilical cord blood. Many people hear "bone marrow donation" and picture a needle in the hip, but peripheral blood collection is now common. In that procedure, the donor receives a growth factor for several days to move blood-forming cells into the bloodstream, and the cells are collected from a vein by a blood separation machine. Which source is used is decided by the transplant team.

How clinic stem cell injections differ
A clinic injection is a different product. Most clinics use mesenchymal stem cells, usually from fat or umbilical cord tissue, which are expanded in culture before being injected or infused. They are promoted for many uses, including joint problems, chronic conditions and aging.
Three differences matter most.
The cells differ. Blood-forming stem cells in a transplant are a defined population that rebuilds the blood system. Cultured mesenchymal cells are a different cell type, expanded in a laboratory.
The purpose differs. A transplant has a specific and established purpose in serious blood disease. A clinic injection is usually offered for a wide range of conditions. The International Society for Stem Cell Research (ISSCR) notes that a single stem cell treatment is unlikely to work for many unrelated diseases, and that very few stem cell treatments have been shown to be safe and effective.
The evidence differs. Transplants are established care with decades of clinical use. For most clinic injections, the evidence is limited, and the research is still at an early stage for most conditions.
How Japan regulates each
In Japan, the two fall under different legal frameworks, and the difference matters for anyone comparing options.

Clinic injections of cultured cells fall under the Act on the Safety of Regenerative Medicine. A clinic must file a provision plan for each treatment, have it reviewed by a certified committee, and file it with the MHLW (or the prefectural Local Bureau of Health and Welfare for Class II and III plans). Donor-derived cells are Class I and require a 90-day review period after filing. Patient-derived cultured cells are usually Class II.
A clinic offering a transplant-type procedure should be able to explain which legal framework applies to it, and to show you the filing or approval that covers it.
Why the comparison is often misleading
Clinic marketing sometimes borrows the credibility of transplants. A claim such as "stem cells are already used to treat leukemia, so they will work for your joints" joins two different cells, two different purposes and two different evidence bases. A transplant that works for blood disease does not show that cultured mesenchymal cells work for joints, diabetes or aging.
The same caution applies to products that are approved in some countries. An approved product is approved for a specific disease and use. It does not show that every stem cell injection works for every condition.
Questions to ask
- Is the procedure a hematopoietic stem cell transplant, or an injection of cultured cells?
- If it is an injection, what is the purpose, and what research supports that purpose for my condition?
- Which legal framework applies, and does the clinic have a filed plan for this exact procedure?
- What are the cells, where do they come from, and how are they processed?

If you or a family member needs a stem cell transplant for a blood condition, the decision belongs with a hematology specialist who can assess the disease and the options. For how clinic treatments in Japan are regulated, read How Japan regulates regenerative medicine. For a related guide to spotting unsupported claims, read Stem cell clinic scams: how to tell legitimate treatment from marketing claims. For the broader evidence on stem cell therapy, read Does stem cell therapy work?
Frequently asked questions
What is "bone marrow donation" now?
Donation of blood-forming stem cells. Most donations today are collected from peripheral blood after a growth factor has moved the cells into the bloodstream. Bone marrow can also be used, in which case it is collected under anesthesia.
Does a stem cell donation require a needle in the bone?
Not always. Peripheral blood collection does not puncture the bone. Bone marrow collection does.
Is a bone marrow transplant the same as a stem cell transplant?
It is one type. A bone marrow transplant is a hematopoietic stem cell transplant with bone marrow as the source. Blood-forming stem cells can also come from peripheral blood or umbilical cord blood, so the general term is hematopoietic stem cell transplant.
If transplants are established, does that mean clinic stem cell injections are reliable?
No. The two use different cells for different purposes, and the evidence for clinic injections is much weaker for most conditions.
Sources: International Society for Stem Cell Research (ISSCR), "9 Things to Know About Stem Cell Treatments" (aboutstemcells.org), points 1, 3 and 4; Act on the Safety of Regenerative Medicine (Act No. 85 of 2013), Articles 2 and 4 (e-Gov, laws.e-gov.go.jp); Enforcement Regulations, Articles 2 and 3 (e-Gov); MHLW, "Regenerative medicine, cell medicine and gene therapy" page. Checked November 2026; MHLW publications prevail.
Medical disclaimer: This site provides general information only and does not constitute medical advice; whether any treatment is suitable for you must be decided by a doctor after an in-person consultation.